Cardinal Health (CAH) Peer Comparison
$247.18
$-1.43
(-0.58%)
As on 04-Sep-2026 16:15EDT
Market cap
$57,821 Mln
Revenue (TTM)
$254,248 Mln
P/E Ratio
33.9
P/B Ratio
16.1
Div. Yield
0.8 %
Edit
| Cardinal Health (CAH) | Eli Lilly and Company (LLY) | Johnson & Johnson (JNJ) | AbbVie (ABBV) | Merck & Company Inc (MRK) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
57,821 | 1,034,063 | 670,988 | 459,822 | 375,849 |
Revenue ($ Mln) |
254,248 | 79,666 | 97,929 | 64,386 | 66,400 |
Net Profit ($ Mln) |
1,714.00 | 26,709.50 | 21,037.00 | 6,314.00 | 3,173.00 |
Net Margin (%) |
0.67 | 33.53 | 21.48 | 9.81 | 4.78 |
RoE (%) |
-60.52 | 88.42 | 25.27 | -- | 6.72 |
Price to Earnings |
33.92 | 38.90 | 31.97 | 74.13 | 122.85 |
Price-To-Book |
16.07 | 30.52 | 7.69 | 50.46 | 8.82 |
Income Statement ($ Mln)
| Cardinal Health (CAH) | Eli Lilly and Company (LLY) | Johnson & Johnson (JNJ) | AbbVie (ABBV) | Merck & Company Inc (MRK) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
254,248.00 | -- | -- | -- | -- |
|
Cost of Revenue
|
244,474.00 | -- | -- | -- | -- |
|
Gross Profit
|
9,774.00 | -- | -- | -- | -- |
|
Operating Expenses
|
7,161.00 | -- | -- | -- | -- |
|
Operating Profit (EBIT)
|
2,613.00 | -- | -- | -- | -- |
|
Other Income
|
-- | -- | -- | -- | -- |
|
Profit before Tax
|
2,174.00 | -- | -- | -- | -- |
|
Provision for Tax
|
469.00 | -- | -- | -- | -- |
|
Profit after Tax (Net Income)
|
1,714.00 | -- | -- | -- | -- |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Consolidated Profit
|
-- | -- | -- | -- | -- |
Liabilities ($ Mln)
| Cardinal Health (CAH) | Eli Lilly and Company (LLY) | Johnson & Johnson (JNJ) | AbbVie (ABBV) | Merck & Company Inc (MRK) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
-2,883.00 | -- | -- | -- | -- |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Non-Current Liabilities
|
16,119.00 | -- | -- | -- | -- |
|
Current Liabilities
|
43,904.00 | -- | -- | -- | -- |
|
Total Liabilities
|
57,299.00 | -- | -- | -- | -- |
Assets ($ Mln)
| Cardinal Health (CAH) | Eli Lilly and Company (LLY) | Johnson & Johnson (JNJ) | AbbVie (ABBV) | Merck & Company Inc (MRK) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
18,546.00 | -- | -- | -- | -- |
|
Current Assets
|
38,753.00 | -- | -- | -- | -- |
|
Total Assets
|
57,299.00 | -- | -- | -- | -- |
|
Total Debt*
|
9,948.00 | -- | -- | -- | -- |
|
Net Current Assets
|
-- | -- | -- | -- | -- |
Cashflow ($ Mln)
| Cardinal Health (CAH) | Eli Lilly and Company (LLY) | Johnson & Johnson (JNJ) | AbbVie (ABBV) | Merck & Company Inc (MRK) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
5,174.00 | -- | -- | -- | -- |
|
Cash Flow from Investing Activities
|
-2,584.00 | -- | -- | -- | -- |
|
Cash from Financing Activities
|
-1,602.00 | -- | -- | -- | -- |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| Cardinal Health (CAH) | Eli Lilly and Company (LLY) | Johnson & Johnson (JNJ) | AbbVie (ABBV) | Merck & Company Inc (MRK) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
25.15 | -- | -- | -- | -- |
|
ROE (%)
|
-60.52 | -- | -- | -- | -- |
|
ROA (%)
|
3.10 | -- | -- | -- | -- |
|
EBIT Margin (%)
|
-- | -- | -- | -- | -- |
|
Net Margin (%)
|
0.67 | -- | -- | -- | -- |
|
Cash Profit Margin (%)
|
-- | -- | -- | -- | -- |
Growth Ratios
| Cardinal Health (CAH) | Eli Lilly and Company (LLY) | Johnson & Johnson (JNJ) | AbbVie (ABBV) | Merck & Company Inc (MRK) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
0.14 | -- | -- | -- | -- |
|
EBIT Growth (%)
|
-- | -- | -- | -- | -- |
|
Net Profit Growth (%)
|
9.80 | -- | -- | -- | -- |
|
EPS Growth (%)
|
0.11 | -- | -- | -- | -- |
|
Book Value Growth (%)
|
-- | -- | -- | -- | -- |
Valuation Ratios
| Cardinal Health (CAH) | Eli Lilly and Company (LLY) | Johnson & Johnson (JNJ) | AbbVie (ABBV) | Merck & Company Inc (MRK) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
32.85 | -- | -- | -- | -- |
|
Price / Book Value
|
-19.53 | -- | -- | -- | -- |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
17.65 | -- | -- | -- | -- |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Cardinal Health (CAH) | Eli Lilly and Company (LLY) | Johnson & Johnson (JNJ) | AbbVie (ABBV) | Merck & Company Inc (MRK) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
-3.45 | -- | -- | -- | -- |
|
Short term debt to equity ratio
|
-0.72 | -- | -- | -- | -- |
|
Current Ratio
|
0.88 | -- | -- | -- | -- |
|
Quick Ratio
|
0.49 | -- | -- | -- | -- |
|
Interest Coverage
|
7.25 | -- | -- | -- | -- |
Operating Efficiency Ratios
| Cardinal Health (CAH) | Eli Lilly and Company (LLY) | Johnson & Johnson (JNJ) | AbbVie (ABBV) | Merck & Company Inc (MRK) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
5.43 | -- | -- | -- | -- |
|
Asset Turnover
|
4.61 | -- | -- | -- | -- |
|
Receivable days
|
19.43 | -- | -- | -- | -- |
|
Inventory Days
|
25.49 | -- | -- | -- | -- |
|
Payable days
|
54.53 | -- | -- | -- | -- |
|
Cash Conversion Cycle
|
-9.60 | -- | -- | -- | -- |
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
